Vaxfab Enterp.

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE560T01015
  • NSEID:
  • BSEID: 542803
INR
43.28
1.77 (4.26%)
BSENSE

Mar 20

BSE+NSE Vol: 2477

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003306,
    "name": "Vaxfab Enterp.",
    "stock_name": "Vaxfab Enterp.",
    "full_name": "Vaxfab Enterprises Ltd",
    "name_url": "stocks-analysis/vaxfab-enterp",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "43.28",
    "chg": 1.77,
    "chgp": "4.26%",
    "dir": 1,
    "prev_price": "41.51",
    "mcapval": "80.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542803,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE560T01015",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": 2477,
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vaxfab-enterp-1003306-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vaxfab Enterprises Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaxfab-enterprises-ltd-is-rated-sell-3893191",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VaxfabEnterpris_mojoScore_3893191.png",
        "date": "2026-03-16 10:10:31",
        "description": "Vaxfab Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vaxfab Enterprises Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaxfab-enterprises-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3857456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VaxfabEnterpris_mojoScore_3857456.png",
        "date": "2026-02-26 08:20:46",
        "description": "Vaxfab Enterprises Ltd, a player in the Trading & Distributors sector, has seen its investment rating downgraded from Hold to Sell as of 25 Feb 2026. This change reflects a complex interplay of deteriorating technical indicators, flat recent financial performance, and valuation considerations despite strong long-term returns and growth metrics."
      },
      {
        "title": "Vaxfab Enterprises Ltd Upgraded to Hold as Technicals and Valuation Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaxfab-enterprises-ltd-upgraded-to-hold-as-technicals-and-valuation-improve-3852376",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VaxfabEnterpris_mojoScore_3852376.png",
        "date": "2026-02-24 08:36:47",
        "description": "Vaxfab Enterprises Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in technical indicators and valuation metrics. Despite flat quarterly financial results, the company’s strong long-term growth, attractive valuation, and improved market momentum have prompted a reassessment of its outlook by analysts."
      },
      {
        "title": "Vaxfab Enterprises Falls 10.80%: Margin Pressures and Downgrade Drive Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaxfab-enterprises-falls-1080-margin-pressures-and-downgrade-drive-weekly-decline-3849458",
        "imagepath": "",
        "date": "2026-02-21 11:02:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Feb 16:</strong> Reports flat quarterly performance amid margin pressures</p>\n                    <p><strong>Feb 16:</strong> Q3 FY26 losses deepen as other income turns sharply negative</p>\n                    <p><strong>Feb 18:</strong> Downgraded to Sell amid flat financials and mixed technical signals</p>\n                    <p><strong>Feb 20:</strong> Week closes at Rs.42.70 (-10.80%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.47.87</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-v..."
      },
      {
        "title": "Vaxfab Enterprises Downgraded to Sell Amidst Flat Financials and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vaxfab-enterprises-downgraded-to-sell-amidst-flat-financials-and-mixed-technical-signals-3845238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VaxfabEnterpris_mojoScore_3845238.png",
        "date": "2026-02-18 08:27:10",
        "description": "Vaxfab Enterprises Ltd, a player in the Trading & Distributors sector, has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its financial performance, valuation metrics, technical indicators, and overall quality scores. The downgrade reflects a shift in the company’s financial trend from positive to flat, coupled with mixed technical signals and valuation concerns despite strong long-term sales growth and return on capital employed."
      },
      {
        "title": "Vaxfab Enterprises Q3 FY26: Losses Deepen as Other Income Turns Sharply Negative",
        "link": "https://www.marketsmojo.com/news/result-analysis/vaxfab-enterprises-q3-fy26-losses-deepen-as-other-income-turns-sharply-negative-3842789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VaxfabEnterpris_quaterlyResult_3842789.png",
        "date": "2026-02-16 14:06:01",
        "description": "Vaxfab Enterprises Limited, a micro-cap fabric and garment trader with a market capitalisation of ₹60.00 crores, reported deepening losses in Q3 FY26 (October-December 2025), posting a consolidated net loss of ₹3.24 crores compared to a profit of ₹6.41 crores in the year-ago quarter. The stock tumbled 9.99% to ₹43.09 following the results announcement, as investors reacted to the sharp deterioration in profitability driven by an unusual ₹3.37 crores negative other income charge. Despite revenue growing 9.28% year-on-year to ₹15.66 crores, operating performance weakened significantly, with operating profit margin contracting to just 2.04% from 13.92% in Q3 FY25."
      },
      {
        "title": "Vaxfab Enterprises Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vaxfab-enterprises-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3842506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VaxfabEnterpris_fintrenddot_3842506.png",
        "date": "2026-02-16 11:00:28",
        "description": "Vaxfab Enterprises Ltd, a player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended December 2025, signalling a notable shift from its previously positive growth trajectory. Despite robust net sales growth and a strong return on capital employed (ROCE), the company’s profitability metrics have deteriorated sharply, raising concerns about margin pressures and operational efficiency."
      },
      {
        "title": "Are Vaxfab Enterprises Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vaxfab-enterprises-ltd-latest-results-good-or-bad-3840613",
        "imagepath": "",
        "date": "2026-02-14 19:59:32",
        "description": "Vaxfab Enterprises Ltd's latest financial results indicate a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. In the first half of FY26, the company reported net sales of ₹69.61 crores, marking a record high for the firm. However, this revenue surge was accompanied by a consolidated net loss of ₹2.25 crores in Q2 FY26, representing a notable shift from previous profitable quarters.\n\nThe financial performance illustrates a dramatic transformation in scale, with net sales for Q1 FY23 at just ₹4.15 crores, contrasting sharply with the current figures. The volatility in profitability is evident, as the company has experienced substantial fluctuations in operating margins, which have ranged from 2.09% to 30.77% in recent quarters. This inconsistency raises questions about the company's ability to manage costs and sustain its business model effective..."
      },
      {
        "title": "When is the next results date for Vaxfab Enterprises Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vaxfab-enterprises-ltd-3833809",
        "imagepath": "",
        "date": "2026-02-11 23:17:24",
        "description": "The next results date for Vaxfab Enterprises Ltd is scheduled for 14 February 2026...."
      }
    ],
    "total": 240,
    "sid": "1003306",
    "stock_news_url": "https://www.marketsmojo.com/news/vaxfab-enterprises-1003306"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "17-Mar-2026",
      "details": "as per attachment",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "25-Feb-2026",
      "details": "as per attachment",
      "source": "BSE"
    },
    {
      "caption": "Results- Financial",
      "datetime": "14-Feb-2026",
      "details": "As attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Vaxfab Enterprises Ltd has announced <strong>6:1</strong> rights issue, ex-date: 03 Jan 23",
          "dt": "2023-01-03",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Vaxfab Enterprises Falls 10.80%: Margin Pressures and Downgrade Drive Weekly Decline

2026-02-21 11:02:18

Key Events This Week

Feb 16: Reports flat quarterly performance amid margin pressures

Feb 16: Q3 FY26 losses deepen as other income turns sharply negative

Feb 18: Downgraded to Sell amid flat financials and mixed technical signals

Feb 20: Week closes at Rs.42.70 (-10.80%)

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Allotment

17-Mar-2026 | Source : BSE

as per attachment

Announcement under Regulation 30 (LODR)-Allotment

25-Feb-2026 | Source : BSE

as per attachment

Results- Financial

14-Feb-2026 | Source : BSE

As attached

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Vaxfab Enterprises Ltd has announced 6:1 rights issue, ex-date: 03 Jan 23